China NMPA Product Recall - Birmingham hip joint modular ball head (femoral component)

Smith & Nephew Medical Products International Trading (Shanghai) Co., Ltd., representing Smith & Nephew Orthopaedics Ltd., initiated a voluntary recall of its Birmingham Hip Replacement System (Modular Ball Head/Femoral Component). This recall, reported to China's National Medical Products Administration (NMPA) on October 11, 2012, was prompted by the product's overall revision rate exceeding established safety benchmarks. Global registry data from England, Wales, and Australia indicated revision rates of 1.29% and 1.12%, surpassing the 1% benchmark set by the UK's National Institute for Health and Care Excellence (NICE). Although no revision reports were received in China since the product's April 2011 introduction, the company proactively responded to the international performance data. Under NMPA oversight, corrective actions include notifying affected customers about proper product usage and updating the instruction manual for submission to China's State Food and Drug Administration. Smith & Nephew Medical Products International Trading (Shanghai) Co., Ltd. is responsible for implementing these actions within China, with provincial authorities supervising the recall process.